ConductScience.org, home

Paper64579

Bleomycin, a review.

Crooke ST and 1 other. J Med, 1976. Cited by 226 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bleomycin, a review. Papers, record 64579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/64579

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bleomycin, a review.
PubMed
Journal
J Med
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
226
iCite
Relative citation ratio, by iCite
9.15
iCite
Revised in PubMed
2015-11-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crooke STS T
2Bradner WTW T

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
Animals
Carcinoma, Squamous Cell
DNA
Drug Therapy, Combination
Head and Neck Neoplasms
Hodgkin Disease
Humans
Lung Neoplasms
Lung Volume Measurements
Lymphoma
Male
Radionuclide Imaging
Testicular Neoplasms

Source PubMed

Download CSV of topics

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 226 citations.

PMIDTitleJournalYearIn PapersSource
39201463Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies.Int J Mol Sci2024https://conductscience.org/library/papers/39201463PubMed
35261136Remarkable efficiency of surgical shave excision of keloids followed by intralesional injection of Bleomycin. A retrospective study of 314 cases.Dermatol Ther2022https://conductscience.org/library/papers/35261136PubMed
33765731Management of keloid scars: noninvasive and invasive treatments.Arch Plast Surg2021https://conductscience.org/library/papers/33765731PubMed
33670189Polyphosphate Reverses the Toxicity of the Quasi-Enzyme Bleomycin on Alveolar Endothelial Lung Cells In Vitro.Cancers (Basel)2021https://conductscience.org/library/papers/33670189PubMed
25141117Update on hypertrophic scar treatment.Clinics (Sao Paulo)2014https://conductscience.org/library/papers/25141117PubMed
24767715Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.Burns2014https://conductscience.org/library/papers/24767715PubMed
21435439Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis.Am J Pathol2011https://conductscience.org/library/papers/21435439PubMed
14506042Fungal cell wall septation and cytokinesis are inhibited by bleomycins.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/14506042PubMed
10757755DNA damage-inducible and RAD52-independent repair of DNA double-strand breaks in Saccharomyces cerevisiae.Genetics2000https://conductscience.org/library/papers/10757755PubMed
9466150Poly(ADP-ribose) synthesis: a useful parameter for identifying apoptotic cells.Histochem J1997https://conductscience.org/library/papers/9466150PubMed
9306543Electrochemotherapy significantly inhibits the growth of colon 26 tumors in mice.Surg Today1997https://conductscience.org/library/papers/9306543PubMed
9252965gamma-Linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters.Lipids1997https://conductscience.org/library/papers/9252965PubMed
7535685Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin: biochemical mechanisms.Environ Health Perspect1994https://conductscience.org/library/papers/7535685PubMed
7504843Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice.Thorax1993https://conductscience.org/library/papers/7504843PubMed
7049331Cancer, chemotherapy and anaesthesia.Can Anaesth Soc J1982https://conductscience.org/library/papers/7049331PubMed
6381742Cancer chemotherapy: past, present, and future--Part I.J Natl Med Assoc1984https://conductscience.org/library/papers/6381742PubMed
6379645Spontaneous and mutagen-induced deletions: mechanistic studies in Salmonella tester strain TA102.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6379645PubMed
6183017Haematopoietic late effects of prolonged bleomycin treatment in mice.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6183017PubMed
6179928cdc9 ligase-defective mutants of Saccharomyces cerevisiae exhibit lowered resistance to lethal effects of bleomycin.J Bacteriol1982https://conductscience.org/library/papers/6179928PubMed
6178526Structure-activity relationships involved in the site-specific fragmentation of linear duplex DNAs by talisomycin and bleomycin analogs.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6178526PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/64579

GET https://conductscience.org/api/papers/v1/64579/cited_by?page=2